Blog and Whitepapers

Recon takes an analytical look behind select developments in healthcare

In this morning’s New York Times (June 3,2014), Andrew Ross Sorkin asks,“DO drug companies make drugs, OR money”? That's a fair question in the context of what I'll call a "fee-for-product" reimbursem…
We use cookies
This website collects cookies to deliver better user experience and to analyze our website traffic and performance; we never collect any personal data or target you with ads.